Vaibhav M. Varkhedkar, BPharm, MS, MBA

As a Vice President in NAXION’s Healthcare and Life Sciences practice, Vaibhav has responsibility for leading strategic engagements to support drug commercialization and life cycle management. He also spearheads the firm’s biotech commercial analytics initiatives, with extensive responsibility for demand forecasting, sales force optimization, and omnichannel marketing modeling initiatives—particularly in oncology, immunology, and rare disease.

As an applied Data Scientist with certification from MIT, he uses advanced AI techniques to elevate strategies and transform raw data into impactful insights. He is especially adept at integrating data from multiple sources to create a truly comprehensive market perspective, ensuring alignment with critical business objectives.

Vaibhav has 30 years of experience in the pharmaceutical and biotech industry, with nearly a decade spent in biotech R&D. Prior consulting and analytics positions include roles at IQVIA, Symphony, Axtria, and ORC International. He has a consistent track record of helping marketing teams drive a strong return on investment and positioning their organizations for long-term growth across diverse regions.

Vaibhav’s ability to align scientific discovery with business growth reflects dual proficiency in bench research and market research. His multi-disciplinary training includes an MS in Medicinal Chemistry from the University of Rhode Island and an MBA from the Fuqua School of Business at Duke University. Vaibhav is a co-author of 15 publications in clinical and business disciplines, with shared credit for 18 U.S. patents and more than two dozen international patents.